Clinical Trial Update: Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing acceptance of a new liquid somatropin formulation for growth hormone deficiency in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Phase 3 | Status: COMPLETED